Print Page   |   Contact Us   |   Sign In   |  
AABANY co-sponsors: Practicing Law In The Pharmaceutical And Biotechnology Industries
Tell a Friend About This EventTell a Friend

AABANY co-sponsors: Practicing Law In The Pharmaceutical And Biotechnology Industries

5/10/2018

When: 05/10/2018
7:00 pm
Where: Morgan, Lewis & Bockius LLP
101 Park Avenue
New York, New York  
United States

Details

To RSVP, please click on the image below.

Peter Tu is currently Vice President, Legal, for Signum Biosciences, a private biotechnology company focusing on the development of novel, small-molecule therapeutics to modulate signal transduction imbalances. In that capacity, Mr. Tu heads up the legal function for Signum and its subsidiaries, and is a member of Signum’s executive management team.

Prior to joining Signum, Mr. Tu was Vice President, Legal, for moksha8 Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on commercialization of pharmaceutical products in emerging markets, where Mr. Tu led the global legal function and was a member of moksha8’s executive management team. Prior to joining moksha8, Mr. Tu was Senior Director of Intellectual Property for Vitae Pharmaceuticals, Inc., where he was responsible for managing Vitae’s patent and intellectual property portfolio, licensing and counseling senior management on a wide variety of intellectual property and other strategic issues. Other previous roles have included the following: Associate General Counsel and Senior Director of Intellectual Property for Savient Pharmaceuticals, Inc., Senior Counsel and Global Licensing Attorney for Hoffmann-La Roche Inc., In-House Patent Counsel and Director of Intellectual Property for Physiome Sciences, Inc. Prior to joining Physiome, Mr. Tu was a senior associate in the Patent Litigation and Counseling Group in the New York office of Weil, Gotshal & Manges. Prior to Weil, Gotshal & Manges, Mr. Tu served as a law clerk for Justice Stewart G. Pollock (NJ Supreme Court) and later for Judge Leonard I. Garth (Court of Appeals for the Third Circuit).

Mr. Tu graduated magna cum laude from Seton Hall Law School, where he served as the Symposium Editor for the Seton Hall Law Review. Mr. Tu also received an MBA in Finance from Seton Hall University and bachelor’s degrees in chemical engineering and biology from MIT.

Jung Choi is Senior Corporate Counsel in the Corporate Governance and Securities group at Bristol-Myers Squibb (BMS), a global biopharmaceutical company focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Jung is responsible for securities law reporting and compliance, as well as financing transactions and corporate governance matters. Jung provides legal counseling to multiple business units including Treasury and Tax on corporate transactions and Investor Relations and Public Affairs on corporate communications. As part of the Corporate Secretary’s Office, she also coordinates the annual meeting process, manages communications between BMS’ senior management, Board of Directors and shareholders and supports several of the Board’s committees.

Prior to joining BMS, Jung was a corporate associate at Davis Polk & Wardwell LLP in New York and Hong Kong where she focused primarily on capital markets transactions. Jung received her J.D., cum laude, from Georgetown University Law Center, and her B.A. in Political Science and International Studies, cum laude, from Yale University. Prior to law school, Jung was a research fellow for the East Asia Regional Security Program at the Henry L. Stimson Center, a nonprofit, nonpartisan think tank in Washington DC.

 
 
 

« Go to Upcoming Event List